262 related articles for article (PubMed ID: 33682294)
1. Systematic insight into the active constituents and mechanism of Guiqi Baizhu for the treatment of gastric cancer.
Li L; Jin XJ; Li JW; Li CH; Zhou SY; Li JJ; Feng CQ; Liu DL; Liu YQ
Cancer Sci; 2021 May; 112(5):1772-1784. PubMed ID: 33682294
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of the anti-gastric cancer mechanism of Guiqi Baizhu Formula by integrative approach of chemical bioinformatics.
Wang Y; Li J; Liu X; Zhang Y; Wang C; Guo Q; Wang Y; Jiang B; Jin X; Liu Y
Int Immunopharmacol; 2024 Jun; 134():112245. PubMed ID: 38749334
[TBL] [Abstract][Full Text] [Related]
3. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis.
Liu J; Liu J; Tong X; Peng W; Wei S; Sun T; Wang Y; Zhang B; Li W
Drug Des Devel Ther; 2021; 15():3255-3276. PubMed ID: 34349502
[TBL] [Abstract][Full Text] [Related]
4. CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer.
Zhang C; Li Z; Xu L; Che X; Wen T; Fan Y; Li C; Wang S; Cheng Y; Wang X; Qu X; Liu Y
BMC Cancer; 2018 Apr; 18(1):462. PubMed ID: 29690901
[TBL] [Abstract][Full Text] [Related]
5. Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of
Babu TM; Rammohan A; Baki VB; Devi S; Gunasekar D; Rajendra W
Drug Des Devel Ther; 2016; 10():3611-3632. PubMed ID: 27853354
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of Astragalus membranaceus (Huangqi, HQ) for treatment of heart failure based on network pharmacology and molecular docking.
Chen Q; Wang J; Sun L; Ba B; Shen D
J Cell Mol Med; 2024 May; 28(10):e18331. PubMed ID: 38780500
[TBL] [Abstract][Full Text] [Related]
7. PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression.
Wu L; Cai S; Deng Y; Zhang Z; Zhou X; Su Y; Xu D
Int Immunopharmacol; 2021 May; 94():107443. PubMed ID: 33581579
[TBL] [Abstract][Full Text] [Related]
8. A Network Pharmacology Analysis of the Active Components of the Traditional Chinese Medicine Zuojinwan in Patients with Gastric Cancer.
Zhang Z; Li B; Huang J; Huang S; He D; Peng W; Zhang S
Med Sci Monit; 2020 Aug; 26():e923327. PubMed ID: 32866138
[TBL] [Abstract][Full Text] [Related]
9. Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1.
Pereira MA; Ramos MFKP; Dias AR; Faraj SF; Ribeiro RRE; de Castria TB; Zilberstein B; Alves VAF; Ribeiro U; de Mello ES
Mol Diagn Ther; 2019 Dec; 23(6):761-771. PubMed ID: 31595457
[TBL] [Abstract][Full Text] [Related]
10. Investigating the therapeutic mechanism of Xiaotan Sanjie Formula for gastric cancer via network pharmacology and molecular docking: A review.
Xu X; Yu Z; Zeng S
Medicine (Baltimore); 2023 Nov; 102(46):e35986. PubMed ID: 37986339
[TBL] [Abstract][Full Text] [Related]
11. Clinic-Pathological Characteristics and Prognostic Value of PD-L1 and HER2 in Gastric Cancer.
Chen L; Wang L; Li X; Zhang G; Li Z; Wang Y
DNA Cell Biol; 2021 Feb; 40(2):405-413. PubMed ID: 33605797
[TBL] [Abstract][Full Text] [Related]
12. Guiqi Baizhu prescription ameliorates cytarabine-induced intestinal mucositis by targeting JAK2 to inhibit M1 macrophage polarization.
Chu W; Li YL; Li JJ; Lin J; Li M; Wang J; He JZ; Zhang YM; Yao J; Jin XJ; Cai H; Liu YQ
Biomed Pharmacother; 2023 Aug; 164():114902. PubMed ID: 37209628
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway.
Wang F; Yang L; Xiao M; Zhang Z; Shen J; Anuchapreeda S; Tima S; Chiampanichayakul S; Xiao Z
Sci Rep; 2022 Jul; 12(1):11444. PubMed ID: 35794161
[TBL] [Abstract][Full Text] [Related]
14. Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer.
Kim YB; Ahn JM; Bae WJ; Sung CO; Lee D
Int J Cancer; 2019 Aug; 145(4):916-926. PubMed ID: 30664822
[TBL] [Abstract][Full Text] [Related]
15. Heterophyllin B inhibits the malignant phenotypes of gastric cancer cells via CXCR4.
Wei Y; Yin L; Zhang J; Tang J; Yu X; Wu Z; Gao Y
Hum Cell; 2023 Mar; 36(2):676-688. PubMed ID: 36539682
[TBL] [Abstract][Full Text] [Related]
16. Systematic Elucidation of the Mechanism of Quercetin against Gastric Cancer via Network Pharmacology Approach.
Yang L; Hu Z; Zhu J; Liang Q; Zhou H; Li J; Fan X; Zhao Z; Pan H; Fei B
Biomed Res Int; 2020; 2020():3860213. PubMed ID: 32964029
[TBL] [Abstract][Full Text] [Related]
17. Identifying cancer-related molecular targets of Nandina domestica Thunb. by network pharmacology-based analysis in combination with chemical profiling and molecular docking studies.
Taha KF; Khalil M; Abubakr MS; Shawky E
J Ethnopharmacol; 2020 Mar; 249():112413. PubMed ID: 31760157
[TBL] [Abstract][Full Text] [Related]
18. Revealing synergistic mechanism of multiple components in Stauntonia brachyanthera Hand.-Mazz. for gout by virtual screening and system pharmacological approach.
Hua QQ; Liu Y; Liu CH; Liu L; Meng DL
Bioorg Chem; 2019 Oct; 91():103118. PubMed ID: 31344517
[TBL] [Abstract][Full Text] [Related]
19. Research on the mechanisms of taraxerol for the treatment of gastric cancer effect based on network pharmacology.
Huo B; Song Y; Tan B; Li J; Zhang J; Zhang F; Chang L
Int J Immunopathol Pharmacol; 2022; 36():20587384211063962. PubMed ID: 34986036
[TBL] [Abstract][Full Text] [Related]
20. Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer.
Ramachandran L; Manu KA; Shanmugam MK; Li F; Siveen KS; Vali S; Kapoor S; Abbasi T; Surana R; Smoot DT; Ashktorab H; Tan P; Ahn KS; Yap CW; Kumar AP; Sethi G
J Biol Chem; 2012 Nov; 287(45):38028-40. PubMed ID: 22992727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
